We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The CSIR-Indian Institute of Chemical Technology (IICT) and Bengaluru-based Anthem Biosciences have entered into an agreement for technology transfer and manufacture of anti-COVID drug 2-DG.